$CTSO News

Cytosorbents Corporation 2026 Q1 - Results - Earnings Call Presentation

Cytosorbents Corporation (CTSO) Q1 2026 Earnings Call Transcript

Transcript: CytoSorbents Q1 2026 Earnings Conference Call

CytoSorbents Q1 Adj. EPS $(0.05) Beats $(0.06) Estimate, Sales $8.864M Miss $9.363M Estimate

CTSO: CytoSorbents Reports Strong 4th Quarter and Full Year 2025 Results

Cytosorbents Corporation 2025 Q4 - Results - Earnings Call Presentation

Cytosorbents (CTSO) Q4 2025 Earnings Transcript

Cytosorbents Corporation Q4 2025 Earnings Call Summary

CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ...

CytoSorbents Corp (NASDAQ:CTSO) Reports Q4 2025 Earnings Miss, Stock Declines

CytoSorbents: Q4 Earnings Snapshot

CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Cytosorbents Corporation (CTSO) Q4 2025 Earnings Call Transcript

CytoSorbents Q4 Adj. EPS $(0.07) Misses $(0.05) Estimate, Sales $9.234M Miss $9.587M Estimate

CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Analysts Expect Breakeven For Cytosorbents Corporation (NASDAQ:CTSO) Before Long

Watching Cytosorbents; Zacks Small-Cap Research Gives Stock $5 Price Valuation

CTSO: CytoSorbents Price Target Increased to $5.00 Based on Higher Than Expected Gross Margins

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update